Ensysce Biosciences ENSC
NASDAQ ENSC
$0.50 0.00 (-0.86%)
At close: Oct 20, 2026 · 4:00 PM EDT

Ensysce Biosciences (ENSC) Total Current Liabilities (2017 - 2025)

Updated

Ensysce Biosciences (ENSC) recorded Total Current Liabilities of $4.57 million in Q4 2025, up 106.9% from $2.21 million a year earlier and up 98.2% from the prior quarter.

Analysis

Ensysce Biosciences (ENSC) Total Current Liabilities (2017 - 2025) Analysis & Trends

Starting with Q4 2017, Ensysce Biosciences' Total Current Liabilities history includes 33 quarters.

  • Annual Total Current Liabilities has a five-year compound annual growth rate of -8.2% (FY2020 to FY2025).
  • Across earlier years, Total Current Liabilities came in at $2.21 million in FY2024 (-33.8%), $3.33 million in FY2023 (-64.8%), $9.46 million in FY2022 (-42.6%) and $16.48 million in FY2021 (+135.1%).
  • The Q4 2025 figure is the highest quarterly Total Current Liabilities since Q4 2022.
  • On a year-over-year basis, Total Current Liabilities rose in four of the last eight quarters, with growth averaging 10.8%.
  • Peak year-over-year performance for Total Current Liabilities in the last five years was growth of 407.7% in Q2 2021, against a decline of 90.9% in Q1 2021 at the low end.
  • Per Business Quant, the preceding three quarters came in at $2.3 million (Q3 2025), $2.51 million (Q2 2025) and $1.76 million (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 47.74 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 54.90 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 41.64 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 27.73 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 31.75 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 31.55 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 25.50 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 11.02 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 32.65 Bn
10 Ensysce Biosciences 1.30 Mn -9.94 Mn - 4.57 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 4.57 Mn
Sep 30, 2025 2.30 Mn
Jun 30, 2025 2.51 Mn
Mar 31, 2025 1.76 Mn
Dec 31, 2024 2.21 Mn
Sep 30, 2024 2.80 Mn
Jun 30, 2024 1.31 Mn
Mar 31, 2024 1.64 Mn
Dec 31, 2023 3.33 Mn
Sep 30, 2023 2.03 Mn
Jun 30, 2023 2.52 Mn
Mar 31, 2023 3.98 Mn
Dec 31, 2022 9.46 Mn
Sep 30, 2022 11.91 Mn
Jun 30, 2022 8.25 Mn
Mar 31, 2022 8.80 Mn
Dec 31, 2021 16.48 Mn
Sep 30, 2021 7.03 Mn
Jun 30, 2021 4.03 Mn
Mar 31, 2021 319,180.00
API Access

Ensysce Biosciences Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=ENSC&period=max&api_key=YOUR_API_KEY